Inside Lyme Podcast with Dr. Daniel Cameron

28-year-old woman with a history of Lyme disease describes side effects following her COVID-19 vaccine – a case discussion

April 02, 2022 Dr. Daniel Cameron Season 4 Episode 55
Inside Lyme Podcast with Dr. Daniel Cameron
28-year-old woman with a history of Lyme disease describes side effects following her COVID-19 vaccine – a case discussion
Show Notes

This case highlights the findings from a COVID-19 & Lyme Survey.

HIGHLIGHTS

Findings: This cross-sectional study reveals a high symptom burden in 1,168 individuals with a history of Lyme Disease. The GSQ-30 measure of symptom burden for 616 individuals with a history of Lyme disease who were vaccinated against COVID-19 was significantly lower than the symptom burden for the 552 who were not vaccinated.

Here are are a few of the case of individuals with Lyme disease who described side effects.

CASE 1:

“After about a week, I began to experience extreme fatigue, difficulties with my lungs (finding it harder to breathe), and heart palpitations. I also struggled to walk any distance as my body would become tired very quickly (these were symptoms I had not experienced for about four years since the start of my Lyme disease treatment).”

CASE 2:

“… got extremely ill, felt like the Lyme and babesia was activated and became as strong as it was before I began treatment (and I was very, very sick by then).”

CASE 3:

“… severe cognitive issues, arm/leg numbness, rage due to light and sound, purple legs sitting and laying down, no short-term memory, speech stuttering, severe word search, muscle weakness, balance, coordination, double blurred vision, dizziness, heavy head, like my head is balancing on a broomstick, and it is a medicine ball, headache around the base of my neck/skull, weight loss, severe fatigue. I would say my pain and fatigue symptoms were 3-4/10 and now they are 8-9/10. The cognitive/ speech/vision/memory problems and purple legs are post-vaccine.”

more see blog at https://danielcameronmd.com/side-effects-covid-19-vaccines-lyme-disease/